Effect of single and multilayered Ti3C2TX MXene as a catalyst and adsorbent on enhanced sonodegradation of diclofenac and verapamil.

Single and multilayered Ti3C2TX MXene (referred to as SLM and MLM in this study, respectively) was applied as catalysts in the ultrasonic (US) process to treat selected pharmaceutical compounds including diclofenac and verapamil (VRP). Due to solid surface, elemental composition, and functional groups of Ti3C2TX MXene, the free OH• production was increased by 48.8% for the US treatment with SLM and 59.8% for the US treatment with MLM compared with the US-only treatment. Additionally, adsorption affected the performance during the US treatment in the presence of the catalyst. Thus, the US treatment in the presence of Ti3C2TX MXene had an enhanced performance not only because of increased oxidation but also because of adsorption, particularly between positively charged VRP and negatively charged Ti3C2TX MXene. Moreover, although the degradation of the performance was higher for SLM (85.1%) than for MLM (81.8%), by improving the dispersion and reducing the size via sonication, the US treatment in the presence of MLM showed the highest synergy effect. In other words, the US treatment in the presence of MLM showed higher performance than the simple sum of oxidation and adsorption. These findings confirm that the US treatment in the presence of MLM may be a promising technology to treat various pharmaceuticals as a more degradable, strongly reusable, and less toxic process.